US securities regulators are examining Apple Inc.’s disclosures about CEO Steve Jobs’ health problems, to ensure investors were not misled. The Securities and Exchange Commission’s review does not mean investigators have seen evidence of wrongdoing. Both the SEC and Apple declined to comment on the matter. Jobs has said he had an easily treatable “hormonal imbalance,” but last week came back to say that his problems were “more complex” than originally thought, and he would take a medical leave of absence for six months. In 2004, Jobs was treated for a rare type of pancreatic cancer called an islet-cell, or neuroendocrine, tumor. Such tumors can be benign or malignant, but they usually grow slowly and are far less deadly than most pancreatic tumors.
Popularity: 6% [?]
